Cooperation between Myc and YY1 provides novel silencing transcriptional targets of α3β1-integrin in tumour cells

被引:41
作者
de Nigris, F.
Botti, C.
Rossiello, R.
Crimi, E.
Sica, V.
Napoli, C.
机构
[1] Univ Naples 2, Sch Med 1, Dept Gen Pathol, Div Clin Pathol, I-80138 Naples, Italy
[2] Univ Naples 2, Sch Med 2, Div Human Pathol, I-80138 Naples, Italy
[3] Berkshire Med Ctr, Dept Internal Med, Pittsfield, MA USA
关键词
YY1; integrin; c-myc; tumours;
D O I
10.1038/sj.onc.1209804
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We show that human osteosarcoma cells (Saos-2) have downregulation of alpha 3 beta 1-integrin compared to normal bone cells; this was further described in human osteosarcomas and in a primary murine sarcoma. The alpha 3 gene was silenced in Saos-2 cells causing a low expression of alpha 3 beta 1-integrin and reduction in collagen attachment with increasing migratory capacity. Chromatin immunoprecipitation assay performed on alpha 3 promoter established that Myc and Yin Yang protein (YY1) cooperate in tandem to downregulate the alpha 3 gene. This silencing mechanism involves the binding of Myc and YY1 to DNA and formation of complexes among Myc/Max, YY1, CREB-binding protein and deacetylation activity. The promoter containing deletions of E-boxes or YY1 cassettes failed to downregulate the transcription of a reporter gene as well as the inhibition of deacetylation activity. Overexpression of both Myc and YY1 was necessary to determine the alpha 3-integrin promoter downregulation in normal osteoblasts. This downregulation of alpha 3 beta 1-integrin can contribute to the acquisition of a more aggressive phenotype. YY1 regulated negatively the Myc activity through a direct interaction with the Myc/Max and deacetylase complexes. This represents a novel silencing mechanism with broad implications in the transcription machinery of tumours.
引用
收藏
页码:382 / 394
页数:13
相关论文
共 34 条
[1]   Medical Progress - Common musculoskeletal tumors of childhood and adolescence [J].
Arndt, CAS ;
Crist, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :342-352
[2]   Integrin β1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo [J].
Brockbank, EC ;
Bridges, J ;
Marshall, CJ ;
Sahai, E .
BRITISH JOURNAL OF CANCER, 2005, 92 (01) :102-112
[3]   Role of oncogenic transcription factor c-Myc in cell cycle regulation, apoptosis and metabolism [J].
Dang, CV ;
Lewis, BC .
JOURNAL OF BIOMEDICAL SCIENCE, 1997, 4 (06) :269-278
[4]  
Davie JR, 1998, J CELL BIOCHEM, P203
[5]   Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits -: Protective effects of vitamin E [J].
de Nigris, F ;
Youssef, T ;
Ciafré, S ;
Franconi, F ;
Anania, V ;
Condorelli, GL ;
Palinski, W ;
Napoli, C .
CIRCULATION, 2000, 102 (17) :2111-2117
[6]   Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues (vol 87, pg 1479, 2002) [J].
de Nigris, F ;
Cerutti, J ;
Morelli, C ;
Califano, D ;
Chiariotti, L ;
Viglietto, G ;
Santelli, G ;
Fusco, A .
BRITISH JOURNAL OF CANCER, 2002, 87 (12) :1479-1479
[7]  
de Nigris F, 2001, CANCER RES, V61, P2267
[8]   c-Myc Oncoprotein Cell Cycle-Related Events and New Therapeutic Challenges in Cancer and Cardiovascular Diseases [J].
de Nigris, Filomena ;
Sica, Vincenzo ;
Herrmann, Joerg ;
Condorelli, Gianluigi ;
Chade, Alejandro R. ;
Tajana, Gianfranco ;
Lerman, Amir ;
Lerman, Lilach O. ;
Napoli, Claudio .
CELL CYCLE, 2003, 2 (04) :325-328
[9]  
Donohoe ME, 1999, MOL CELL BIOL, V19, P7237
[10]   CLONING OF A NEGATIVE TRANSCRIPTION FACTOR THAT BINDS TO THE UPSTREAM CONSERVED REGION OF MOLONEY MURINE LEUKEMIA-VIRUS [J].
FLANAGAN, JR ;
BECKER, KG ;
ENNIST, DL ;
GLEASON, SL ;
DRIGGERS, PH ;
LEVI, BZ ;
APPELLA, E ;
OZATO, K .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (01) :38-44